Skip to content
stoqly

Cabot

CBT NYSE Diversified Chemicals Financials FY2016–FY2025

Cabot's revenue fell 7.0% to $3.7 billion in fiscal 2025. Its operating margin was 16.7%, up from 15.4% a year earlier. Free cash flow was $391 million, down 13.3%. It paid out $264 million in dividends and buybacks, 68% of free cash flow. The diluted share count fell 2.7%.

Last close · Oct 23, 2026

$73.79

0.7%
Value it Compare
Revenue Total sales reported in the income statement.
$3.7B
7.0% vs prior year
Operating margin Operating income as a share of revenue.
16.7%
1.4 pts
Net income Profit after all expenses, interest and tax.
$331M
12.9%
Free cash flow Cash from operations minus capital spending.
$391M
13.3%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
15.9%
3.6 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$3.9B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
12.9x
On $5.72 EPS (TTM)

What Cabot does

No business description yet.

Legal name
CABOT CORP
Fiscal year ends
September 30, 2025
Latest annual report
—
Accession · CIK
0001193125-25-292412
0000016040

Revenue and margins

Cabot had $3.7B of revenue in fiscal 2025, down 7.0% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew 11.2% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $391M in fiscal 2025, 10.5% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Cabot returned $264M to shareholders in fiscal 2025, 68% of free cash flow. The diluted share count fell 2.7%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Cabot yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.

Discounted cash flow

Value per share

—

Adds net cash of −$878M and divides by 54.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

—

Reference multiples: today 12.9x · peers 46.2x · sector 20.6x.

Balance sheet

Cash, debt and the ratios that show how comfortably Cabot can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $168M$206M$238M$223M$258M
Debt incl. finance leases $1.2B$1.5B$1.3B$1.1B$1.1B
Net debt / EBITDA 1.6x2.3x1.6x1.2x1.1x
Debt / equity 1.2x1.6x1.0x0.8x0.7x
Interest coverage 9.3x7.0x5.8x7.6x8.2x
Current ratio 1.2x1.7x2.0x2.1x1.6x
Quick ratio 0.8x1.1x1.3x1.4x1.1x
Total assets $3.3B$3.5B$3.6B$3.7B$3.8B
Total liabilities $2.2B$2.5B$2.2B$2.1B$2.1B
Shareholders' equity $947M$898M$1.3B$1.4B$1.6B
Net debt (− = net cash) $998M$1.2B$1.0B$924M$878M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$19.6M

1 insider

Of sales under plans

0%

$0.0M

DateInsiderTradeSharesPriceValueFiling
Aug 28, 2026 Sean D KeohanePresident and CEO, Director Sold 134,895 $85.00 $11.5M Form 4
Aug 24, 2026 Sean D KeohanePresident and CEO, Director Sold 2,779 $85.50 $0.2M Form 4
Aug 7, 2026 Sean D KeohanePresident and CEO, Director Sold 91,923 $86.41 $7.9M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive ✓ ✓ ✓
Cash from operations is positive ✓ ✓ ✓
Return on assets rose ✓ ✕ ✕
Cash from operations exceeds net income ✓ ✓ ✓
Debt fell relative to assets ✓ ✓ ✓
Current ratio rose ✓ ✓ ✕
Share count didn't rise ✓ ✓ ✓
Gross margin rose ✓ ✓ ✓
Revenue rose relative to assets ✕ ✕ ✕
F-score 8 / 97 / 96 / 9
Accruals ratio −4.2%−8.5%−8.9%
Altman Z'' 4.544.864.51

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Cabot CBT $3.9B −7.0% 16.7% 10.5% 15.9% 12.9x 6
Chemours CC $1.9B 0.5% — 0.9% −0.2% — 4 Compare →
Olin OLN $1.8B 3.7% 0.1% 3.7% 0.1% — 4 Compare →
Ashland Global ASH $3.4B −13.7% −42.5% 2.0% −17.5% 69.5x 5 Compare →
AptarGroup ATR $8.1B 5.4% 13.3% 7.9% 11.4% 22.8x 7 Compare →

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $2.4B $2.7B $3.2B $3.3B $2.6B $3.4B $4.3B $3.9B $4.0B $3.7B
Gross profit $575M $657M $772M $685M $500M $799M $885M $839M $960M $940M
Research and development $53.0M $57.0M $66.0M $60.0M $57.0M $56.0M $55.0M $57.0M $63.0M $59.0M
Operating income $247M $338M $144M $306M $21.0M $454M $389M $526M $614M $621M
Interest expense $54.0M $53.0M $54.0M $59.0M $53.0M $49.0M $56.0M $90.0M $81.0M $76.0M
Pretax income $191M $299M $117M $255M −$33.0M $406M $335M $451M $529M $565M
Income tax $33.0M $33.0M $193M $70.0M $191M $123M $102M −$28.0M $111M $196M
Net income $147M $248M −$113M $157M −$238M $250M $209M $445M $380M $331M
Diluted EPS $2.32 $3.91 −$1.85 $2.63 −$4.21 $4.34 $3.62 $7.73 $6.72 $6.02
Diluted shares 0.06B 0.06B 0.06B 0.06B 0.06B 0.06B 0.06B 0.06B 0.06B 0.05B
Cash flow
Cash from operations $392M $348M $298M $363M $377M $257M $100M $595M $692M $665M
Capital expenditure $112M $147M $229M $224M $200M $195M $211M $244M $241M $274M
Free cash flow $280M $201M $69.0M $139M $177M $62.0M −$111M $351M $451M $391M
Depreciation and amortization $161M $155M $149M $148M $158M $160M $146M $144M $151M $154M
Stock-based compensation $17.0M $16.0M $22.0M $11.0M $9.0M $21.0M $23.0M $20.0M $25.0M $24.0M
Acquisitions $0.0M $0.0M $64.0M $3.0M $92.0M $0.0M $9.0M $0.0M $0.0M $27.0M
Share buybacks $45.0M $61.0M $142M $173M $44.0M $3.0M $53.0M $98.0M $172M $168M
Dividends paid $65.0M $77.0M $80.0M $80.0M $80.0M $80.0M $84.0M $88.0M $93.0M $96.0M
Dividends and buybacks $110M $138M $222M $253M $124M $83.0M $137M $186M $265M $264M
Balance sheet
Cash and short-term investments $200M $280M $175M $169M $151M $168M $206M $238M $223M $258M
Total debt $914M $915M $996M $1.1B $1.1B $1.1B $1.4B $1.3B $1.1B $1.1B
Finance lease liabilities $0.0M $0.0M $0.0M $12.0M $31.0M $33.0M $29.0M $28.0M $27.0M $30.0M
Current assets $1.0B $1.3B $1.4B $1.2B $978M $1.4B $1.8B $1.6B $1.6B $1.5B
Current liabilities $397M $742M $952M $599M $529M $1.1B $1.1B $822M $772M $957M
Inventory $342M $433M $511M $466M $359M $523M $664M $585M $552M $504M
Property and equipment, net $1.3B $1.3B $1.3B $1.3B $1.3B $1.4B $1.3B $1.4B $1.5B $1.7B
Total assets $3.1B $3.3B $3.2B $3.0B $2.8B $3.3B $3.5B $3.6B $3.7B $3.8B
Total liabilities $1.6B $1.7B $2.0B $1.9B $2.0B $2.2B $2.5B $2.2B $2.1B $2.1B
Shareholders' equity $1.3B $1.5B $1.2B $998M $691M $947M $898M $1.3B $1.4B $1.6B
Margins
Gross margin 23.9% 24.2% 23.8% 20.5% 19.1% 23.4% 20.5% 21.3% 24.0% 25.3%
Operating margin 10.2% 12.4% 4.4% 9.2% 0.8% 13.3% 9.0% 13.4% 15.4% 16.7%
EBITDA margin 16.9% 18.2% 9.0% 13.6% 6.9% 18.0% 12.4% 17.0% 19.2% 20.9%
Net margin 6.1% 9.1% −3.5% 4.7% −9.1% 7.3% 4.8% 11.3% 9.5% 8.9%
FCF margin 11.6% 7.4% 2.1% 4.2% 6.8% 1.8% −2.6% 8.9% 11.3% 10.5%
Returns
Return on capital 9.4% 13.8% 3.3% 10.7% 0.9% 16.4% 12.4% 22.2% 19.5% 15.9%
Return on capital employed 9.4% 12.9% 5.9% 13.0% 0.9% 20.6% 17.0% 20.2% 21.4% 21.3%
Return on equity 11.7% 17.9% −8.5% 14.6% −28.2% 30.5% 22.7% 41.2% 28.3% 22.3%
Return on assets 4.8% 7.8% −3.4% 5.0% −8.2% 8.2% 6.1% 12.5% 10.4% 8.8%
Growth
Revenue growth −16.0% 12.7% 19.3% 2.9% −21.7% 30.4% 26.8% −9.0% 1.6% −7.0%
Net income growth — 68.7% −145.6% — −251.6% — −16.4% 112.9% −14.6% −12.9%
EPS growth — 68.5% −147.3% — −260.1% — −16.6% 113.5% −13.1% −10.4%
FCF growth −21.8% −28.2% −65.7% 101.5% 27.3% −65.0% −279.0% — 28.5% −13.3%
Share count change −0.8% −0.3% −1.6% −4.7% −3.7% 0.4% 0.2% −0.7% −1.4% −2.7%
Financial health
Net debt / EBITDA 1.8x 1.3x 2.8x 2.0x 5.4x 1.6x 2.3x 1.6x 1.2x 1.1x
Debt / equity 0.7x 0.6x 0.9x 1.1x 1.6x 1.2x 1.6x 1.0x 0.8x 0.7x
Interest coverage 4.6x 6.4x 2.7x 5.2x 0.4x 9.3x 7.0x 5.8x 7.6x 8.2x
Current ratio 2.6x 1.8x 1.5x 2.0x 1.9x 1.2x 1.7x 2.0x 2.1x 1.6x
Quick ratio 1.8x 1.2x 0.9x 1.2x 1.2x 0.8x 1.1x 1.3x 1.4x 1.1x
Capital allocation
Capex / revenue 4.7% 5.4% 7.1% 6.7% 7.7% 5.7% 4.9% 6.2% 6.0% 7.4%
Stock comp / revenue 0.7% 0.6% 0.7% 0.3% 0.3% 0.6% 0.5% 0.5% 0.6% 0.7%
Payouts / FCF 39.3% 68.7% 321.7% 182.0% 70.1% 133.9% — 53.0% 58.8% 67.5%
Quality scores
Piotroski F-score 8.0 8.0 4.0 7.0 3.0 7.0 4.0 8.0 7.0 6.0
Altman Z'' 4.5 4.4 3.3 4.1 2.7 3.1 3.7 4.5 4.9 4.5
Accruals ratio −8.0% −3.1% −12.5% −6.6% −21.3% −0.2% 3.2% −4.2% −8.5% −8.9%

Source: SEC EDGAR XBRL filings (CIK 0000016040). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open